BioSpace News Archive

Mindset Pharma Inc. and PharmAla Biotech Holdings Inc. today announced that they have entered into an exclusive sales agreement.

Oncotelic Therapeutics, Inc, a developer of treatments for rare and orphan indications, including Parkinson’s Disease, PDAC, DIPG, and COVID-19, announced the publication of the presentation materials from SITC 37th annual meeting held in Boston, MA on November 10th-12th, 2022 on our website.

Concord Medical Services Holdings Limited announced the successful holding of the Second Annual Academic Meeting jointly by Shanghai Concord Cancer Center and The University of Texas MD Anderson Cancer Center on November 11 and November 12, 2022.

Kriya Therapeutics, Inc. today announced the acquisition of Redpin Therapeutics, Inc., a privately held biotechnology company developing regulatable gene therapies for intractable diseases of the nervous system.

Kinarus Therapeutics Holding AG announced that it has engaged Great Health Companion Group Ltd, a subsidiary of Hakim Unique Group, a global conglomerate from China, to explore partnering options to initiate Phase 2 testing of KIN001 to treat wet age-related macular degeneration and idiopathic pulmonary fibrosis.

Alvotech, a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, reported unaudited financial results for the first nine months of 2022 and provided a summary of recent corporate highlights.

Curapath, a leader in the design, development, and custom manufacturing of polyamino-acid- and lipid-based nanoparticle delivery systems for therapeutics and vaccines, announced a collaboration with Afrigen Biologics to advance the development of the first African-owned mRNA SARS-Cov-2 vaccine.

Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the 34th Annual Piper Sandler Healthcare Conference at The Lotte New York Palace, New York, NY, on Wednesday, November 30, 2022 at 1:30 p.m. (ET).

Eagle Pharmaceuticals, Inc. today announced that the following speakers and world-renowned Key Opinion Leaders will be featured at the Company’s Investor Day on Tuesday, December 6, 2022, at the Lotte New York Palace Hotel, at 8:00am ET.

AccuStem Sciences, Inc. announced today the appointment of Sean McDonald to its Board of Directors which will now comprise five members.